Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to ...

When it comes to fighting rare diseases ... rare and ultra-rare diseases.” In an effort to give researchers the best possible start when developing treatments for eye diseases, The Foundation ...

The FDA has granted a fast review for Horizon Therapeutics’ teprotumumab for active thyroid eye disease (TED), a rare vision-threatening autoimmune condition. After accepting Horizon’s filing ...